BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 34964038)

  • 41. T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?
    Kroeze E; Loeffen JLC; Poort VM; Meijerink JPP
    Blood Adv; 2020 Jul; 4(14):3466-3473. PubMed ID: 32722786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutation.
    Ripperger T; Beger C; Rahner N; Sykora KW; Bockmeyer CL; Lehmann U; Kreipe HH; Schlegelberger B
    Haematologica; 2010 May; 95(5):841-4. PubMed ID: 20015892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).
    Leenders EKSM; Westdorp H; Brüggemann RJ; Loeffen J; Kratz C; Burn J; Hoogerbrugge N; Jongmans MCJ
    Eur J Hum Genet; 2018 Oct; 26(10):1417-1423. PubMed ID: 29904176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Position paper: Challenges and specific strategies for constitutional mismatch repair deficiency syndrome in low-resource settings.
    Kebudi R; Amayiri N; Abedalthagafi M; Rana AN; Kirmani S; Musthaq N; Lamki ZA; Houdzi JE; Yazici H; El-Naggar S; Edwards M; Bianchi VJ; Durno C; Tabori U; Bouffet E;
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28309. PubMed ID: 32472748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Constitutional MMR deficiency: Genetic bases and clinical implications].
    Buecher B; Le Mentec M; Doz F; Bourdeaut F; Gauthier-Villars M; Stoppa-Lyonnet D; Colas C
    Bull Cancer; 2019 Feb; 106(2):162-172. PubMed ID: 30551794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?
    Hoelzer D; Gökbuget N
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S214-21. PubMed ID: 19778844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood.
    Tabori U; Hansford JR; Achatz MI; Kratz CP; Plon SE; Frebourg T; Brugières L
    Clin Cancer Res; 2017 Jun; 23(11):e32-e37. PubMed ID: 28572265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature.
    Vezzoli P; Novara F; Fanoni D; Gambini D; Balice Y; Venegoni L; Paulli M; Crosti C; Berti E
    Leuk Lymphoma; 2012 Oct; 53(10):1978-87. PubMed ID: 21879810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pediatric High Grade Gliomas in the Context of Cancer Predisposition Syndromes.
    Michaeli O; Tabori U
    J Korean Neurosurg Soc; 2018 May; 61(3):319-332. PubMed ID: 29742882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort.
    Kroeze E; Weijers DD; Hagleitner MM; de Groot-Kruseman HA; Jongmans MCJ; Kuiper RP; Pieters R; Meijerink JPP; Loeffen JLC
    Hemasphere; 2022 Jan; 6(1):e668. PubMed ID: 34964038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome.
    Ripperger T; Schlegelberger B
    Eur J Med Genet; 2016 Mar; 59(3):133-42. PubMed ID: 26743104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD).
    Wimmer K; Kratz CP; Vasen HF; Caron O; Colas C; Entz-Werle N; Gerdes AM; Goldberg Y; Ilencikova D; Muleris M; Duval A; Lavoine N; Ruiz-Ponte C; Slavc I; Burkhardt B; Brugieres L;
    J Med Genet; 2014 Jun; 51(6):355-65. PubMed ID: 24737826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome.
    Westdorp H; Kolders S; Hoogerbrugge N; de Vries IJM; Jongmans MCJ; Schreibelt G
    Cancer Lett; 2017 Sep; 403():159-164. PubMed ID: 28645564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1.
    Wimmer K; Rosenbaum T; Messiaen L
    Clin Genet; 2017 Apr; 91(4):507-519. PubMed ID: 27779754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.